Pfizer Inc. Issues a Voluntary Nationwide Recall for 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products

[ad_1]

Pfizer Inc. is voluntarily recalling RELPAX® (eletriptan hydrobromide) 40 mg tablets, heaps AR5407 and CD4565, to the Affected person degree. Pfizer Inc. initiated this recall as a result of these product heaps could not meet Pfizer’s in-house microbiological specification for the potential presence of Genus Pseudomona

[ad_2]

Source link